Elonox and Elonox HP (enoxaparin sodium)

pCPA File Number: 21904
Negotiation Status:
Active Negotiation
Indication(s):
Prevention or treatment of thrombosis and cardiovascular conditions
Sponsor/Manufacturer:
Fresenius Kabi Canada Ltd.
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable